Topical cream found as less-toxic therapy to treat cutaneous leishmaniasis

Paromomysin-based topical treatments were shown to be effective in curing cutaneous leishmaniasis (CL), according to a randomized, double blind study conducted in Panama. Leishmaniasis, transmitted by a female phlebotomine sand fly bite, is endemic in 98 countries and has approximately 0.7 to 1.2 million CL cases each year.